Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.44
5.86%
After-hours: Aug 15, 2025, 07:59 PM EDT
Matinas BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -20.08M | -24.25M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.31M | -23.28M | -22.92M | -21.54M | -22.36M |
Depreciation & Amortization | 855K | 968K | 961K | 959K | 952K | 941K | 926.82K | 919.61K | 915.47K | 898K | 877.29K | 842.54K | 795.46K | 781.49K | 767.33K | 759.91K | 773.69K |
Stock-Based Compensation | 2.52M | 3.19M | 4.22M | 4.45M | 4.67M | 4.95M | 5.02M | 5.23M | 5.24M | 5.23M | 4.96M | 4.61M | 4.45M | 4.29M | 4.44M | 4.33M | 4.22M |
Other Working Capital | 1.45M | 288K | -527K | -24K | 630K | 1.89M | 117.23K | -1.2M | -3.35M | -4.47M | -1.12M | -1.4M | 1.05M | 945.13K | 236.89K | 1.08M | 239.46K |
Other Non-Cash Items | 4.32M | 5.85M | 3.59M | 3.6M | 3.67M | 2.18M | 145.25K | 176.23K | 195.91K | 504K | 526.98K | 1.74M | 1.75M | 1.45M | 1.62M | 235.25K | -278.29K |
Deferred Income Tax | n/a | n/a | -2.07M | -2.07M | -2.07M | -2.07M | n/a | n/a | n/a | n/a | 2.21K | 2.21K | 2.21K | 2.21K | n/a | n/a | n/a |
Change in Working Capital | 1.07M | -131K | -1.01M | -390K | 588K | 1.67M | 175.79K | -1.21M | -4.31M | -4.79M | -1.12M | -1.36M | 1.98M | 1.53M | 525.82K | 1.04M | -292.22K |
Operating Cash Flow | -12.12M | -15.88M | -16.95M | -17.87M | -16.96M | -15.28M | -15M | -15.55M | -18.49M | -19.16M | -18.81M | -19.6M | -15.33M | -15.22M | -15.57M | -15.05M | -17.35M |
Capital Expenditures | n/a | n/a | n/a | -16K | -218K | -218K | -259.6K | -493.95K | -347.44K | -892K | -886.59K | -860.43K | -804.94K | -260.38K | -218.44K | 5.75K | 5.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 0.75 | 0.75 | 3.74M | 3.74M | 3.68M | 3.68M | -56.65K | -56.65K | n/a | n/a | n/a |
Purchase of Investments | -8.44M | -8.44M | -8.44M | n/a | n/a | n/a | -412 | -412 | -6.99M | -9.48M | -14.89M | -25.55M | -21.61M | -23.19M | -15.69M | -11.57M | -14.98M |
Sales Maturities Of Investments | 15.64M | 17.64M | 20.11M | 11.06M | 12.46M | 13.46M | 4.5M | 9.4M | 6.25M | 9.25M | 20.75M | 25.88M | 33.33M | 40.23M | 41.72M | 34.35M | 38.1M |
Other Investing Acitivies | n/a | 2M | 4.96M | -1.88M | 12.46M | 13.46M | 16.5M | 21.4M | 11.26M | 11.77M | 5.83M | 292.54K | 11.68M | 16.99M | 16.93M | 13.68M | 14.02M |
Investing Cash Flow | 7.21M | 9.21M | 11.67M | 3.11M | 12.24M | 13.24M | 10.24M | 14.91M | 4.92M | 4.88M | 4.98M | -531.27K | 10.91M | 16.77M | 25.8M | 22.78M | 23.12M |
Debt Repayment | -4K | -5K | -5K | -4K | -4K | -7K | -11K | -13K | -18K | -20K | -20.54K | -25.86K | -28.02K | -30K | -32.28K | -34.57K | -42.71K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2K | n/a | n/a | n/a | n/a | n/a | 800.00 | 800.00 | 800.00 | 99.8K | 112.63K | 112.63K | 301.26K | 1.41M | 1.89M | 1.96M | 1.77M |
Financial Cash Flow | 10.77M | 9.17M | 9.17M | 9.24M | 50K | -7K | -11K | -13K | -18K | 79K | 92.33K | 87.01K | 273.48K | 6.96M | 7.51M | 7.57M | 7.39M |
Net Cash Flow | 5.85M | 2.5M | 3.89M | -5.53M | -4.67M | -2.04M | -4.77M | -655.54K | -13.59M | -14.2M | -13.75M | -20.04M | -4.14M | 8.51M | 17.74M | 15.3M | 13.16M |
Free Cash Flow | -12.12M | -15.88M | -16.95M | -17.89M | -17.18M | -15.5M | -15.26M | -16.04M | -18.83M | -20.05M | -19.7M | -20.46M | -16.13M | -15.48M | -15.79M | -15.04M | -17.35M |